Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study (CERETI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01823159
Recruitment Status : Completed
First Posted : April 4, 2013
Last Update Posted : December 2, 2014
Sponsor:
Collaborators:
GlaxoSmithKline
Université Catholique de Louvain
Information provided by (Responsible Party):
Michel Ossemann, University Hospital of Mont-Godinne

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2013
Actual Study Completion Date : January 2014